Taipei mayoral election campaigns have been clouded by issues concerning Taiwan’s COVID-19 response and vaccine procurement over the past two years.
As Democratic Progressive Party (DPP) Taipei mayoral candidate Chen Shih-chung (陳時中) was head of the Central Epidemic Command Center (CECC) for more than 900 days during the COVID-19 pandemic, his political opponents have been attacking him for what they called “poor COVID-19 responses.”
The Chinese Nationalist Party’s (KMT) Legislator and Taipei mayoral candidate Chiang Wan-an (蔣萬安) and independent Taipei mayoral candidate Vivian Huang (黃珊珊), a former Taipei deputy mayor, have aggressively and negatively campaigned against Chen.
Since Chen announced his bid for mayor in July, he has been called a “runaway CECC head,” criticized for cutting quarantine time and causing local COVID-19 outbreaks, branded incapable of securing enough vaccines last year, and accused of blocking vaccine purchases, concealing vaccine prices and wasting taxpayer money by disposing of expired vaccines.
Huang said that Chen was “murdering for money,” as she claimed the government had blocked the purchase of imported vaccines to profit from Taiwan’s homegrown Medigen COVID-19 vaccine.
Chiang also said Chen showed “disregard for human lives” and “had no empathy for the victims’ families,” while the KMT legislative caucus last week filed a complaint against him for alleged dereliction of duty in purchasing COVID-19 vaccines.
When the local outbreak of the Omicron variant of SARS-CoV-2 began in April, the KMT consistently called for Chen to step down as CECC head due to his “poor COVID-19 response,” but it criticized him for “running away” when he resigned in July after the infections stabilized. Daily local caseloads dropped to about 20,000 from the peak of about 90,000, while antiviral drug prescriptions and COVID-19 hospital bed vacancy rates were high.
The KMT legislative caucus in July 2020 urged the government to allocate more funding for domestic COVID-19 vaccine development and ease clinical trial requirements due to fears that the nation would not gain access to vaccine supplies as fast as other countries. After the government purchased vaccines, the KMT later labeled the AstraZeneca vaccine “unwanted” and dangerous, saying it could cause blood clots. It called receivers of the Medigen vaccine “lab rats,” demanded a greater supply of the Pfizer-BioNTech vaccine and questioned whether vaccines had been purchased at inflated prices.
The KMT’s demands — buying vaccines before other countries at low cost, providing vaccine brand variety, revealing non-disclosure agreements, not wasting taxpayers’ money by purchasing too many doses, while also funding research for domestically made vaccines — are basically impossible.
In January last year, Israel was ahead of many bigger countries in COVID-19 vaccination rates. It paid a premium to get early Pfizer-BioNTech vaccines, agreeing to provide the vaccine company with efficacy data among those vaccinated. Although its contract with Pfizer was made public shortly after it was signed, the specifics around the cost were redacted.
Pfizer-BioNTech had stated that it uses “a tiered pricing formula based on volume and delivery dates,” and the CECC has clarified that a non-disclosure agreement was signed with the vaccine manufacturers, yet the KMT continues to obscure the facts.
While many countries have reported destroying millions of expired COVID-19 vaccines, including the US, which discarded 82.1 million doses from December 2020 to mid-May, the KMT continues to attack Chen for the disposal of Taiwan’s expired vaccines.
Negative campaigning focused on previous COVID-19 policies does not improve the well-being of Taipei residents. Debates on policies for better municipal governance would be more constructive.
A gap appears to be emerging between Washington’s foreign policy elites and the broader American public on how the United States should respond to China’s rise. From my vantage working at a think tank in Washington, DC, and through regular travel around the United States, I increasingly experience two distinct discussions. This divergence — between America’s elite hawkishness and public caution — may become one of the least appreciated and most consequential external factors influencing Taiwan’s security environment in the years ahead. Within the American policy community, the dominant view of China has grown unmistakably tough. Many members of Congress, as
After declaring Iran’s military “gone,” US President Donald Trump appealed to the UK, France, Japan and South Korea — as well as China, Iran’s strategic partner — to send minesweepers and naval forces to reopen the Strait of Hormuz. When allies balked, the request turned into a warning: NATO would face “a very bad” future if it refused. The prevailing wisdom is that Trump faces a credibility problem: having spent years insulting allies, he finds they would not rally when he needs them. That is true, but superficial, as though a structural collapse could be caused by wounded feelings. Something
Former Taipei mayor and Taiwan People’s Party (TPP) founding chairman Ko Wen-je (柯文哲) was sentenced to 17 years in prison on Thursday, making headlines across major media. However, another case linked to the TPP — the indictment of Chinese immigrant Xu Chunying (徐春鶯) for alleged violations of the Anti-Infiltration Act (反滲透法) on Tuesday — has also stirred up heated discussions. Born in Shanghai, Xu became a resident of Taiwan through marriage in 1993. Currently the director of the Taiwan New Immigrant Development Association, she was elected to serve as legislator-at-large for the TPP in 2023, but was later charged with involvement
Out of 64 participating universities in this year’s Stars Program — through which schools directly recommend their top students to universities for admission — only 19 filled their admissions quotas. There were 922 vacancies, down more than 200 from last year; top universities had 37 unfilled places, 40 fewer than last year. The original purpose of the Stars Program was to expand admissions to a wider range of students. However, certain departments at elite universities that failed to meet their admissions quotas are not improving. Vacancies at top universities are linked to students’ program preferences on their applications, but inappropriate admission